Brief: Egetis Therapeutics Q2 Loss Narrows To SEK 33.2 Mln

Egetis Therapeutics AB (publ)

19/08/2022 07:15

Aug 19 (Reuters) - Egetis Therapeutics AB (publ)  EGTX.ST :
    * Q2 REVENUES MSEK 4.7 (25.0)
    * Q2 LOSS MSEK -33.2 (-34.3)

Source text for Eikon:  ID:nMFNbS1WWs 
Further company coverage:  EGTX.ST 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))